Day One Biopharmaceuticals, Inc. (DAWN)

DAWN Revenue

In the year 2024, Day One Biopharmaceuticals had annual revenue of $131.16M. Day One Biopharmaceuticals had revenue of $29.21M in the quarter ending December 31, 2024.

• Revenue (ttm): $131.16M
• Revenue Growth: n/a
• P/S Ratio: 6.18
• Revenue / Employee: $724,646
• Employees: 181
• Market Cap: 873.17M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	131.16M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.